There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...

The Centers for Disease Control and Prevention (CDC) on Thursday reported more than 1,000 measles cases nationwide. That is ...

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

The U.S. Centers for Disease Control and Prevention in a report on Thursday said that hospitalizations related to RSV ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

Experts have pointed to RSV vaccine campaigns as a possible reason why. A separate CDC report shows that infant hospitalizations in the 2024-25 respiratory virus season were more than 40% lower than ...

Maternal RSV vaccination and nirsevimab (a long-acting monoclonal antibody) administration were introduced during the 2023–2024 U.S. RSV season. A study published in MMWR assessed the association ...

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings, ...

The nation’s infant mortality rate dropped last year after two years of hovering at a late-pandemic plateau. Some experts think one reason for the drop could be a vaccination campaign against RSV, or ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...